Breaking News: Itafos Gives Green Light to Husky 1 North Dry Ridge Project – Get Ready for Some Serious Mineral Resource Action Until 20371!

Itafos Announces Notice to Proceed for Husky 1/North Dry Ridge; Solidifying the Potential for Mineral Resources The Exciting News! Wow, talk about a major milestone for Itafos! All the hard work and collaboration with various stakeholders has finally paid off as the Notice to Proceed (“NTP”) for the Husky 1/North Dry Ridge (“H1/NDR”) mine development…

Read More

DTX Exchange’s DTX Pre-Sale Takes the Spotlight with Exciting DeFi Features and Support from Near Protocol and Pepe

As the bitcoin turns bullish, various altcoins in the crypto world follow suit Near Protocol and PEPE Gain Massive Support As the cryptocurrency market continues to show bullish signs, altcoins like Near Protocol and PEPE are gaining significant support from investors. Near Protocol, the market leader in AI cryptocurrency by market capitalization, has been particularly…

Read More

“Unlocking Success: Tune in to Amgen’s 2024 Q4 and Full Year Financial Results Webcast!”

Welcome to Amgen’s Fourth Quarter and Full Year 2024 Financial Results Report THOUSAND OAKS, Calif., Jan. 31, 2025 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2024 financial results on Tuesday, February 4, 2025, after the close of the U.S. financial markets. Exciting news from Amgen Amgen,…

Read More

60 Years of Success: Hecla Rings the NYSE Closing Bell® to Celebrate Milestone on the New York Stock Exchange

Hecla Mining Company Celebrates 60 Years on the NYSE Ring the Closing Bell at the NYSE COEUR D’ALENE, Idaho–(BUSINESS WIRE)–Hecla Mining Company (NYSE:HL) is proud to announce that it will ring the New York Stock Exchange (NYSE) Closing Bell® on Thursday, November 21, 2024, at 4:00 p.m. Eastern Time, commemorating 60 years of being listed…

Read More

Unleashing the Power of Possibility: A Recap of Catalyst Pharmaceuticals Inc.’s Q3 2024 Earnings Call

Welcome to the Catalyst Pharmaceuticals, Inc. Q3 2024 Earnings Conference Call Key Players in the Call Richard Daly, President and Chief Executive Officer of Catalyst Pharmaceuticals, Inc., kicked off the call with an overview of the company’s performance in the third quarter. Michael Kalb, Chief Financial Officer, provided detailed financial results. Jeffrey Del Carmen, Chief…

Read More